Yinmin Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yinmin Wang has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
Jun Yang
Department of Plastic and Reconstructive Surgery, Shanghai Jiao Tong University School of Medicine Affiliated Ninth People's Hospital, Shanghai, China
5 shared publicationsRui Jin
Department of Plastic and Reconstructive Surgery, Shanghai Jiao Tong University School of Medicine Affiliated Ninth People's Hospital, Shanghai, China
5 shared publications- Jun Yang
Department of Plastic and Reconstructive Surgery, Shanghai Ninth People’s Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, People’s Republic of China
4 shared publications Lin Lu
Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, People's Republic of China
4 shared publications- Xusong Luo
Department of Plastic and Reconstructive Surgery Shanghai Ninth People's Hospital Shanghai Jiaotong University School of Medicine Shanghai China
4 shared publications Chuan Gu
Department of Plastic and Reconstructive Surgery, Shanghai Ninth People’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
3 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by Wiley in Dermatologic Therapy
- Vol. 2026 (1)
Insights Into the Role of Mitophagy and Immune Infiltration in Keloids
Background: Keloids, while considered a benign skin condition, can lead to significant discomfort. The exact mechanisms behind their development remain obscure. Methods: The objective of the current investigation was to find key genes involved in keloid formation and explore the interactions between mitophagy and the immune microenvironment. Datasets GSE145725 and GSE7890 were sourced from the Gene Expression Omnibus (GEO) database. Differentially expressed genes (DEGs) together with module genes were found and subjected to functional enrichment analysis. To investigate mitophagy‐related hub genes and their role in keloid pathology, machine learning (ML) techniques, including least absolute shrinkage and selection operator (LASSO) regression and random forest, were applied. A nomogram was created using the found hub genes. The immune landscape was analyzed using single‐sample gene set enrichment analysis (ssGSEA). Hub gene protein expression and immune cell infiltration in clinical samples were evaluated using Western blot analysis and immunofluorescence labeling. Results: Four hub genes related to mitochondrial autophagy—ARHGAP29, PLXDC2, YPEL3, and ENTPD7—were identified through ML. A diagnostic nomogram model constructed from these four genes demonstrated high reliability and accuracy. The immune microenvironment varied between keloid and control groups, with Spearman correlation analysis revealing both positive and negative associations between the hub genes and infiltrating immune cells. Additionally, reduced protein expression of ARHGAP29 and YPEL3, along with increased infiltration of CD8+ T cells, was observed in keloid tissues. Conclusion: This work offers a thorough examination of immune infiltration and mitophagy in keloid development.
- 1 January 2026
- Published by Wiley in Dermatologic Therapy
- Vol. 2026 (1)
Open AccessInsights Into the Role of Mitophagy and Immune Infiltration in Keloids
Background: Keloids, while considered a benign skin condition, can lead to significant discomfort. The exact mechanisms behind their development remain obscure. Methods: The objective of the current investigation was to find key genes involved in keloid formation and explore the interactions between mitophagy and the immune microenvironment. Datasets GSE145725 and GSE7890 were sourced from the Gene Expression Omnibus (GEO) database. Differentially expressed genes (DEGs) together with module genes were found and subjected to functional enrichment analysis. To investigate mitophagy‐related hub genes and their role in keloid pathology, machine learning (ML) techniques, including least absolute shrinkage and selection operator (LASSO) regression and random forest, were applied. A nomogram was created using the found hub genes. The immune landscape was analyzed using single‐sample gene set enrichment analysis (ssGSEA). Hub gene protein expression and immune cell infiltration in clinical samples were evaluated using Western blot analysis and immunofluorescence labeling. Results: Four hub genes related to mitochondrial autophagy—ARHGAP29, PLXDC2, YPEL3, and ENTPD7—were identified through ML. A diagnostic nomogram model constructed from these four genes demonstrated high reliability and accuracy. The immune microenvironment varied between keloid and control groups, with Spearman correlation analysis revealing both positive and negative associations between the hub genes and infiltrating immune cells. Additionally, reduced protein expression of ARHGAP29 and YPEL3, along with increased infiltration of CD8+ T cells, was observed in keloid tissues. Conclusion: This work offers a thorough examination of immune infiltration and mitophagy in keloid development.
- Open Access
- 29 December 2025
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 83 (1) , 8
VAMP4 in hypoxic adipose stem cell exosomes alleviates ischemia-reperfusion injury
Ischemia/reperfusion injury (I/RI) impedes the progress of flap and allograft transplantation. Among various strategies to address oxidative stress (OS) and mitochondrial dysfunction associated with I/RI, exosomes derived from adipose-derived stem cells (ADSCs) subjected to hypoxia pretreatment show significant therapeutic potential. This study assessed the effects of ADSC-derived exosomes (ADSC-Ex) from normoxic and hypoxic conditions on reactive oxygen species (ROS), mitochondrial calcium ion (Ca2+) influx, mitochondrial potential, and cell apoptosis in an ischemia/reperfusion (I/R) model. Mass spectrometry (MS) was utilized to analyze differentially expressed proteins in hypoxic ADSC-Ex compared to normoxic controls. The functions of significantly upregulated proteins were investigated through knockdown experiments in hypoxic ADSC-Ex on alleviating I/R injury (I/RI) in HUVECs. Hypoxic ADSC-Ex significantly mitigated I/RI in vascular endothelial cells both in vitro and in vivo. This effect was associated with reduced ROS and mitochondrial Ca2+ influx, and protection of mitochondrial potential. MS identified several proteins that were significantly upregulated in hypoxic ADSC-Ex, with Vesicle-associated membrane protein 4 (VAMP4) emerging as a pivotal molecule involved in alleviating I/RI in vascular endothelial cells. This study demonstrated that hypoxic ADSC-Ex reduced ROS and mitochondrial dysfunction in vascular endothelial cells through VAMP4, thereby attenuating I/RI. This finding might provide a new approach for treating post-transplant I/RI.
- 29 December 2025
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 83 (1) , 8
Open AccessVAMP4 in hypoxic adipose stem cell exosomes alleviates ischemia-reperfusion injury
Ischemia/reperfusion injury (I/RI) impedes the progress of flap and allograft transplantation. Among various strategies to address oxidative stress (OS) and mitochondrial dysfunction associated with I/RI, exosomes derived from adipose-derived stem cells (ADSCs) subjected to hypoxia pretreatment show significant therapeutic potential. This study assessed the effects of ADSC-derived exosomes (ADSC-Ex) from normoxic and hypoxic conditions on reactive oxygen species (ROS), mitochondrial calcium ion (Ca2+) influx, mitochondrial potential, and cell apoptosis in an ischemia/reperfusion (I/R) model. Mass spectrometry (MS) was utilized to analyze differentially expressed proteins in hypoxic ADSC-Ex compared to normoxic controls. The functions of significantly upregulated proteins were investigated through knockdown experiments in hypoxic ADSC-Ex on alleviating I/R injury (I/RI) in HUVECs. Hypoxic ADSC-Ex significantly mitigated I/RI in vascular endothelial cells both in vitro and in vivo. This effect was associated with reduced ROS and mitochondrial Ca2+ influx, and protection of mitochondrial potential. MS identified several proteins that were significantly upregulated in hypoxic ADSC-Ex, with Vesicle-associated membrane protein 4 (VAMP4) emerging as a pivotal molecule involved in alleviating I/RI in vascular endothelial cells. This study demonstrated that hypoxic ADSC-Ex reduced ROS and mitochondrial dysfunction in vascular endothelial cells through VAMP4, thereby attenuating I/RI. This finding might provide a new approach for treating post-transplant I/RI.
- Open Access
- 26 November 2025
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 24 (12) , e70569
Single‐Cell Atlas of Aging Human Skin Reveals FOSB ‐Related Transcriptional Programs and Druggable Targets
Background: While human skin aging involves complex transcriptional alterations, the cell‐type‐specific regulatory mechanisms and therapeutic targets remain incompletely defined. The study aims to investigate aging‐associated transcriptional programs and drug‐responsive signatures at single‐cell resolution. Method: Here we performed a single‐cell RNA sequencing of young and elder human skin cells and provided a comprehensive analysis of aging‐related genes, a gene regulatory network with immunohistochemistry (IHC) validation, cell–cell interference as well as potential chemical reactions. Result: Total 10 distinct cell populations were analyzed based on the scRNA sequencing data. Gene regulatory network analysis showed decreased lactotransferrin gene expression and increased FOSB(+) and DDIT3(+) regulons' regulatory activity. IHC identified the FOSB as an aging‐related transcription factor. Despite uniform MT1 protein distribution across epidermal layers, single‐cell data revealed subcluster‐specific MT1 mRNA dynamics linked to metal ion homeostasis. Drug response prediction experiments revealed possible drug targets and potential antiaging drugs for the skin. Conclusion: Our data showed the skin cell clusters presented distinct transcriptional signatures during skin aging. We highlighted the versatile expression profiles of metallothionein family genes and identified the aging‐related signature FOSB in the aged skin. We also provided potential target resources for antiaging therapies.
- 26 November 2025
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 24 (12) , e70569
Open AccessSingle‐Cell Atlas of Aging Human Skin Reveals FOSB ‐Related Transcriptional Programs and Druggable Targets
Background: While human skin aging involves complex transcriptional alterations, the cell‐type‐specific regulatory mechanisms and therapeutic targets remain incompletely defined. The study aims to investigate aging‐associated transcriptional programs and drug‐responsive signatures at single‐cell resolution. Method: Here we performed a single‐cell RNA sequencing of young and elder human skin cells and provided a comprehensive analysis of aging‐related genes, a gene regulatory network with immunohistochemistry (IHC) validation, cell–cell interference as well as potential chemical reactions. Result: Total 10 distinct cell populations were analyzed based on the scRNA sequencing data. Gene regulatory network analysis showed decreased lactotransferrin gene expression and increased FOSB(+) and DDIT3(+) regulons' regulatory activity. IHC identified the FOSB as an aging‐related transcription factor. Despite uniform MT1 protein distribution across epidermal layers, single‐cell data revealed subcluster‐specific MT1 mRNA dynamics linked to metal ion homeostasis. Drug response prediction experiments revealed possible drug targets and potential antiaging drugs for the skin. Conclusion: Our data showed the skin cell clusters presented distinct transcriptional signatures during skin aging. We highlighted the versatile expression profiles of metallothionein family genes and identified the aging‐related signature FOSB in the aged skin. We also provided potential target resources for antiaging therapies.
- Open Access
- 1 August 2025
- Published by Taylor & Francis in Biologics: Targets and Therapy
- Vol. ume 19, 497-510
Therapeutic Potential of Compounds with High Affinity to BAG2 in Inhibiting Keloid Disease
Purpose: Targeting the distinct genetic and protein expression profiles of keloids necessitates the identification of novel therapeutic targets. This study was aimed to elucidate the role of Bcl-2-associated athanogene 2 (BAG2) in keloid pathology and identify compounds with high-affinity to BAG2. Patients and Methods: Cell migration, and cell proliferation assays, along with flow cytometry, were used to evaluate the effects of BAG2 on keloid fibroblasts (KFs) derived from tissue samples of patients with abdominal or chest keloids. Additionally, histological examinations and Western blotting were performed to investigate BAG2’s role in keloids. Surface plasmon resonance (SPR) was employed to identify compounds with high-affinity to BAG2, and the effects of these compounds on keloids was assessed. Results: Inhibition of BAG2 significantly decreased collagen deposition, cell proliferation and migration in keloid tissues. The modulatory effect of BAG2 on these processes appears to be mediated partly by the MEK signaling pathway. Among the tested compounds, Bazedoxifene acetate and Ponesimod showed high affinity for BAG2 and demonstrated a more pronounced inhibitory effect on collagen deposition of the keloid tissues than other candidates. Conclusion: This study revealed the pathogenic role of BAG2 in keloid and identified compounds with high-affinity to BAG2, Bazedoxifene acetate and Ponesimod. The therapeutic capabilities of these compounds demonstrated their potential to improve therapeutic strategies for localized, targeted treatment to keloids.
- 1 August 2025
- Published by Taylor & Francis in Biologics: Targets and Therapy
- Vol. ume 19, 497-510
Open AccessTherapeutic Potential of Compounds with High Affinity to BAG2 in Inhibiting Keloid Disease
Purpose: Targeting the distinct genetic and protein expression profiles of keloids necessitates the identification of novel therapeutic targets. This study was aimed to elucidate the role of Bcl-2-associated athanogene 2 (BAG2) in keloid pathology and identify compounds with high-affinity to BAG2. Patients and Methods: Cell migration, and cell proliferation assays, along with flow cytometry, were used to evaluate the effects of BAG2 on keloid fibroblasts (KFs) derived from tissue samples of patients with abdominal or chest keloids. Additionally, histological examinations and Western blotting were performed to investigate BAG2’s role in keloids. Surface plasmon resonance (SPR) was employed to identify compounds with high-affinity to BAG2, and the effects of these compounds on keloids was assessed. Results: Inhibition of BAG2 significantly decreased collagen deposition, cell proliferation and migration in keloid tissues. The modulatory effect of BAG2 on these processes appears to be mediated partly by the MEK signaling pathway. Among the tested compounds, Bazedoxifene acetate and Ponesimod showed high affinity for BAG2 and demonstrated a more pronounced inhibitory effect on collagen deposition of the keloid tissues than other candidates. Conclusion: This study revealed the pathogenic role of BAG2 in keloid and identified compounds with high-affinity to BAG2, Bazedoxifene acetate and Ponesimod. The therapeutic capabilities of these compounds demonstrated their potential to improve therapeutic strategies for localized, targeted treatment to keloids.
- 21 July 2025
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 49 (16) , 4607-4614
The Role of Epicanthoplasty Modification in Revising Unsatisfactory Upper Blepharoplasty Outcomes: A Retrospective Study
Background The epicanthal fold affects the aesthetic outcome of blepharoplasty in Asians. Thus, blepharoplasty in scenarios with an unmatched epicanthal fold and double eyelid may lead to unsatisfactory results. Restoring the medial canthal region to harmonize with the double eyelid is vital for achieving an upper-eyelid appearance. Methods In this study, sixteen patients who underwent epicanthoplasty from 2019 to 2023 with a history of unsatisfactory blepharoplasty and an unmatched epicanthal fold were included in this study. The epicanthoplasty was performed based on a four-point homologous design, and the palpebral fissure length (PFL), interepicanthal distance (IED), canthal tilt angle (CTA), and distance from the medial canthus to the beginning of the double-eyelid fold distance (CFD) were recorded preoperatively and 6 months postoperatively. Results In all patients, complete surgical healing was achieved within 2 weeks. The CTA, IED, and CFD significantly decreased after surgical treatment, and PFL increased during the 6-month follow-up. Most patients were satisfied with the results during long-term follow-ups. Conclusion The epicanthoplasty modification described in this study improved the morphology of the upper eyelid, offering stable outcomes and simpler procedures. Further, we described a decision-making strategy for revisional blepharoplasty. This strategy might be an ideal reparative option for patients with unsatisfactory out-fold type double eyelids and the epicanthus not coordinating with the double eyelid, providing a promising alternative for unsatisfactory blepharoplasty. Level of Evidence IV This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
- 21 July 2025
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 49 (16) , 4607-4614
The Role of Epicanthoplasty Modification in Revising Unsatisfactory Upper Blepharoplasty Outcomes: A Retrospective Study
Background The epicanthal fold affects the aesthetic outcome of blepharoplasty in Asians. Thus, blepharoplasty in scenarios with an unmatched epicanthal fold and double eyelid may lead to unsatisfactory results. Restoring the medial canthal region to harmonize with the double eyelid is vital for achieving an upper-eyelid appearance. Methods In this study, sixteen patients who underwent epicanthoplasty from 2019 to 2023 with a history of unsatisfactory blepharoplasty and an unmatched epicanthal fold were included in this study. The epicanthoplasty was performed based on a four-point homologous design, and the palpebral fissure length (PFL), interepicanthal distance (IED), canthal tilt angle (CTA), and distance from the medial canthus to the beginning of the double-eyelid fold distance (CFD) were recorded preoperatively and 6 months postoperatively. Results In all patients, complete surgical healing was achieved within 2 weeks. The CTA, IED, and CFD significantly decreased after surgical treatment, and PFL increased during the 6-month follow-up. Most patients were satisfied with the results during long-term follow-ups. Conclusion The epicanthoplasty modification described in this study improved the morphology of the upper eyelid, offering stable outcomes and simpler procedures. Further, we described a decision-making strategy for revisional blepharoplasty. This strategy might be an ideal reparative option for patients with unsatisfactory out-fold type double eyelids and the epicanthus not coordinating with the double eyelid, providing a promising alternative for unsatisfactory blepharoplasty. Level of Evidence IV This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
- 31 December 2024
- Published by Oxford University Press (OUP) in Aesthetic Surgery Journal
- Vol. 45 (4) , 341-346
A Stepwise Approach to Surgical Decision-making for Lower Eyelid Ectropion: Insights from a Retrospective Study
Background: Cicatricial lower eyelid ectropion is a serious complication resulting from undesired lower lid blepharoplasty or impaired wound healing. Surgical treatment for ectropion is challenging for oculoplastic surgeons due to the unpredictability of surgical outcome and the difficulty of surgical design. Objectives: The authors aimed to fully describe the surgical decision-making strategy for cicatricial ectropion, and to potentially enhance treatment outcomes. Methods: In this study, we conducted a retrospective review of the treatment of 26 patients (30 eyelids) with cicatricial ectropion between 2017 and 2021. We summarized the corresponding decision-making processes before and during surgery. Treatment involved scar tissue release combined with lateral canthal procedures and repair of the skin defect. Results: During the early postoperative stage, no flap necrosis was observed, and complete surgical healing was achieved within 2 weeks. The ectropion grading scale showed a significant decrease after surgical treatment based on our approach, and most patient symptoms were alleviated. Additionally, the majority of the patients expressed high satisfaction with the aesthetic outcome of the procedure. Conclusions: This treatment approach significantly enhanced both the appearance and function of the lower lid, which holds considerable promise as an ideal surgical design for cicatricial ectropion. Level of Evidence: 3 (Therapeutic):
- 31 December 2024
- Published by Oxford University Press (OUP) in Aesthetic Surgery Journal
- Vol. 45 (4) , 341-346
A Stepwise Approach to Surgical Decision-making for Lower Eyelid Ectropion: Insights from a Retrospective Study
Background: Cicatricial lower eyelid ectropion is a serious complication resulting from undesired lower lid blepharoplasty or impaired wound healing. Surgical treatment for ectropion is challenging for oculoplastic surgeons due to the unpredictability of surgical outcome and the difficulty of surgical design. Objectives: The authors aimed to fully describe the surgical decision-making strategy for cicatricial ectropion, and to potentially enhance treatment outcomes. Methods: In this study, we conducted a retrospective review of the treatment of 26 patients (30 eyelids) with cicatricial ectropion between 2017 and 2021. We summarized the corresponding decision-making processes before and during surgery. Treatment involved scar tissue release combined with lateral canthal procedures and repair of the skin defect. Results: During the early postoperative stage, no flap necrosis was observed, and complete surgical healing was achieved within 2 weeks. The ectropion grading scale showed a significant decrease after surgical treatment based on our approach, and most patient symptoms were alleviated. Additionally, the majority of the patients expressed high satisfaction with the aesthetic outcome of the procedure. Conclusions: This treatment approach significantly enhanced both the appearance and function of the lower lid, which holds considerable promise as an ideal surgical design for cicatricial ectropion. Level of Evidence: 3 (Therapeutic):
- 24 May 2024
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 145 (1) , 77-84.e6
Identifying Potential Drug Targets for Keloid: A Mendelian Randomization Study
- 24 May 2024
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 145 (1) , 77-84.e6
Identifying Potential Drug Targets for Keloid: A Mendelian Randomization Study
- Open Access
- 1 December 2023
- Published by KEAI Publishing in Chinese Journal of Plastic and Reconstructive Surgery
- Vol. 5 (4) , 182-184
A two-step correction of a congenital alar cleft in an adult patient: A case report
- 1 December 2023
- Published by KEAI Publishing in Chinese Journal of Plastic and Reconstructive Surgery
- Vol. 5 (4) , 182-184
Open AccessA two-step correction of a congenital alar cleft in an adult patient: A case report
- 2 May 2023
- Published by SAGE Publications in Facial Plastic Surgery & Aesthetic Medicine
- Vol. 25 (3) , 238-243
Surgical Correction of a Bifid Nose Deformity with a Split M-Shaped Flap
Background: Bifid nose is a representative indicator of a facial cleft in patients with frontonasal dysplasia. There is no consensus on effective methods to correct bifid nose deformities due to their varied expressions and limited reports of surgical treatments. In this article, we propose using a split M-shaped flap to treat severe dorsal and alar deformities in patients with a bifid nose. Methods: From 2012 to 2021, a total of 26 bifid nose patients underwent surgical correction of their nasal deformities, which were characterized by cleft and board dorsum, alar defects, shortened nose, and shortened or absent nasal tip. These surgeries were performed with the transposition of an M-shaped split flap. Nasal length and nasolabial angle were assessed before and after surgery. Indications, outcomes, and complications were analyzed. Patient satisfaction was evaluated using a self-assessment survey. Results: Postoperative evaluation showed stable results with increased nasal length and improved nasal appearance. Complications were seen in difficulty breathing through the nose and persistent nostril deformities. The majority of patients (92.3%) were satisfied with their surgical outcome. Conclusion: Split M-shaped flap for bifid nose treatment provides improved nasal appearance with a high patient acceptance and stable postoperative results. Clinical Trial registration: chictr.org identifier ChiCTR2000039275
- 2 May 2023
- Published by SAGE Publications in Facial Plastic Surgery & Aesthetic Medicine
- Vol. 25 (3) , 238-243
Surgical Correction of a Bifid Nose Deformity with a Split M-Shaped Flap
Background: Bifid nose is a representative indicator of a facial cleft in patients with frontonasal dysplasia. There is no consensus on effective methods to correct bifid nose deformities due to their varied expressions and limited reports of surgical treatments. In this article, we propose using a split M-shaped flap to treat severe dorsal and alar deformities in patients with a bifid nose. Methods: From 2012 to 2021, a total of 26 bifid nose patients underwent surgical correction of their nasal deformities, which were characterized by cleft and board dorsum, alar defects, shortened nose, and shortened or absent nasal tip. These surgeries were performed with the transposition of an M-shaped split flap. Nasal length and nasolabial angle were assessed before and after surgery. Indications, outcomes, and complications were analyzed. Patient satisfaction was evaluated using a self-assessment survey. Results: Postoperative evaluation showed stable results with increased nasal length and improved nasal appearance. Complications were seen in difficulty breathing through the nose and persistent nostril deformities. The majority of patients (92.3%) were satisfied with their surgical outcome. Conclusion: Split M-shaped flap for bifid nose treatment provides improved nasal appearance with a high patient acceptance and stable postoperative results. Clinical Trial registration: chictr.org identifier ChiCTR2000039275
- Open Access
- 1 December 2022
- Published by KEAI Publishing in Chinese Journal of Plastic and Reconstructive Surgery
- Vol. 4 (4) , 154-157
A combined therapy for the repair of alar defects that consists of a modified spiral flap and postoperative nasal stent
- 1 December 2022
- Published by KEAI Publishing in Chinese Journal of Plastic and Reconstructive Surgery
- Vol. 4 (4) , 154-157
Open AccessA combined therapy for the repair of alar defects that consists of a modified spiral flap and postoperative nasal stent